Schneider Eugene

Schneider Eugene is listed in filings as EVP at Ionis Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Mar 23, 2026, including sale activity. Recent filings connect the profile to Ionis Pharmaceuticals Inc (IONS). The current snapshot covers public activity from Jan 6, 2026 to Mar 23, 2026. Reported amounts are shown as $1.5M to $515.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.